Low serum albumin levels and in-hospital adverse outcomes in acute coronary syndrome

International Heart Journal

Volumn 51, Issue 4, 2010, Pages 221-226

  Hartopo, Anggoro Budi ^a   Gharini, Putrika Prastuti Ratna ^a   Setianto, Budi Yuli ^a  

^a GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Acute coronary syndrome; Hypoalbuminemia; In hospital adverse outcomes; Serum albumin

Indexed keywords

ALBUMIN; DOBUTAMINE; DOPAMINE; FIBRINOLYTIC AGENT; FUROSEMIDE; HEPARIN; INOTROPIC AGENT; LOOP DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADULT; ADVERSE OUTCOME; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOGENIC SHOCK; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART REINFARCTION; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; INCIDENCE; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE CORONARY SYNDROME; ADULT; AGED; COHORT STUDIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 77955834726     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.221     Document Type: Article

References (22)

1. Peters T Jr. Serum albumin. Adv Protein Chem 1985; 37: 161-245. (Review)
2. Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia 1998; 53: 789-803. (Review)
3. Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) Study. Am J Epidemiol 2000; 151: 468-477.
4. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.
5. Djoussé L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 2002; 106: 2919-2924.
6. Weijenberg MP, Feskens EJ, Souverijn JH, Kromhout D. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology 1997; 8: 87-92.
7. Gillum RF, Makuc DM. Serum albumin, coronary heart disease, and death. Am Heart J 1992; 123: 507-513.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. (Review)
9. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850. (Review)
10. Carter AM, Catto AJ, Mansfield MW, Bamford JM, Grant PJ. Predictive variables for mortality after acute ischemic stroke. Stroke 2007; 38: 1873-80.
11. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610-1619.
12. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266. (Review)
13. Zoellner H, Höfler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996; 109: 2571-2780.
14. Watts JA, Maiorano PC. Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts. J Mol Cell Cardiol 1999; 31: 1653-1662.
15. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 2002; 55: 820-829.
16. Gresele P, Deckmyn H, Huybrechts E, Vermylen J. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. Biochem Pharmacol 1984; 33: 2083-2088.
17. Maalej N, Albrecht R, Loscalzo J, Folts JD. The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces. J Am Coll Cardiol 1999; 33: 1408-1414.
18. Joles JA, Willekes-Koolschijn N, Koomans HA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int 1997; 52: 761-770.
19. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17: 432-437. (Review)
20. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482.
21. Katayama T, Nakashima H, Takagi C, et al. Prognostic significance of time-delay to peak creatine kinase after direct percutaneous coronary intervention in acute myocardial infarction patients. Int Heart J 2005; 46: 771-781.
22. Boos CJ, Soor SK, Kang D, Lip GY. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. Eur Heart J 2007; 28: 1092-1101.